AZTR on NYSE
Azitra, Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with GENELUX Corp, SYNLOGIC, INC. or Aspire-Lakewood Holdings, Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Service revenue - related party | $0 | $7.5K |
| Total revenue | $0 | $7.5K |
| General and administrative | $6.1M | $6.3M |
| Research and development | $4.8M | $4.7M |
| Total operating expenses | $11.0M | $11.0M |
| Loss from operations | -$11.0M | -$11.0M |
| Interest income | $70.2K | $122.6K |
| Interest expense | -$7.6K | -$12.2K |
| Change in fair value of warrants | $381 | $4.0M |
| Loss on issuance of common stock | $0 | -$2.1M |
| Other (expense) income | -$43.4K | $15.0K |
| Total other income | $19.6K | $2.0M |
| Loss before income taxes | -$10.9M | -$9.0M |
| Income tax expense | -$8.3K | -$9.0K |
| Net loss attributable to common shareholders | -$11.0M | -$9.0M |
| Net loss per share, basic (in dollars per share) | -$2.25 | -$15.70 |
| Net loss per share, diluted (in dollars per share) | -$2.25 | -$15.70 |
| Weighted average common stock outstanding, basic (in shares) | 4.9M shares | 571.2K shares |
| Weighted average common stock outstanding, diluted (in shares) | 4.9M shares | 571.2K shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2025-07-31 | 2025-06-30 |
|---|---|---|---|
| Cash and cash equivalents | $2.1M | ||
| Accounts receivable | $912 | ||
| Tax credits receivable | $140.4K | ||
| Deferred offering costs | $0 | ||
| Prepaid expenses | $809.9K | ||
| Total current assets | $3.0M | ||
| Property and equipment, net | $548.6K | ||
| Financing lease right-of-use asset, net | $9.0K | ||
| Operating lease right-of-use asset, net | $404.4K | ||
| Intangible assets, net | $316.7K | ||
| Deferred patent costs | $679.9K | ||
| Deferred issuance costs | $0 | ||
| Other assets | $47.4K | ||
| Total assets | $5.0M | ||
| Accounts payable | $399.4K | ||
| Income tax payable | $6.3K | ||
| Current financing lease liability | $10.1K | ||
| Current operating lease liability | $255.8K | ||
| Insurance premium financing liability | $199.0K | ||
| Accrued expenses | $197.5K | ||
| Total current liabilities | $1.1M | ||
| Long-term financing lease liability | $0 | ||
| Long-term operating lease liability | $156.2K | ||
| Warrant liability | $0 | ||
| Total liabilities | $1.2M | ||
| Preferred stock; $0.0001 par value; 10,000,000 shares authorized at December 31, 2025 and December 31, 2024; 0 shares issued at December 31, 2025 and December 31, 2024 | $0 | ||
| Common stock; $0.0001 par value, 200,000,000 and 100,000,000 shares authorized at December 31, 2025 and December 31, 2024, respectively, 10,740,697 and 1,145,038 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $1.1K | ||
| Additional paid-in capital | $72.3M | ||
| Accumulated deficit | -$68.5M | ||
| Total stockholders' equity | $3.8M | $2.2M | |
| Total liabilities and stockholders' equity | $5.0M | ||
| Preferred stock, par value (in dollars per share) | $0.00 | ||
| Preferred stock, shares authorized (in shares) | 10.0M shares | ||
| Preferred stock, shares issued (in shares) | 0 shares | ||
| Common stock, par value per share (in dollars per share) | $0.00 | ||
| Common stock, shares authorized (in shares) | 200.0M shares | 200.0M shares | 100.0M shares |
| Common stock, shares issued (in shares) | 10.7M shares | ||
| Common stock, shares outstanding (in shares) | 10.7M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$11.0M | -$9.0M |
| Depreciation and amortization | $138.1K | $131.2K |
| Loss on lease modification | $10.9K | $0 |
| Amortization of right-of-use assets | $315.1K | $317.0K |
| Change in foreign currency rates on remeasurement of Canadian fixed assets | $0 | -$14.2K |
| Stock based compensation | $62.7K | $245.1K |
| Change in fair value of warrant liability | -$381 | -$4.0M |
| Loss on issuance of common stock | $0 | $2.1M |
| Loss on disposal of property and equipment | $2.1K | $4.9K |
| Impairment of intangible assets and deferred patent costs | $0 | $442.8K |
| Accounts receivable | -$679 | $98.0K |
| Prepaid expenses | $53.2K | -$119.3K |
| Other assets | -$461 | $819 |
| Tax credits receivable | -$38.7K | $16.7K |
| Income tax payable/receivable | -$5.3K | $18.4K |
| Accounts payable and accrued expenses | -$500.3K | -$140.5K |
| Operating lease liability | -$304.9K | -$315.8K |
| Net cash used in operating activities | -$11.2M | -$10.2M |
| Purchases of property and equipment | -$24.2K | -$8.6K |
| Proceeds from sale of property and equipment | $3.2K | $0 |
| Deferred patent costs | -$161.8K | -$370.7K |
| Net cash used in investing activities | -$182.9K | -$379.2K |
| Payment of deferred offering/issuance costs | -$286 | -$37.5K |
| Principal payments on finance leases | -$16.1K | -$14.6K |
| Proceeds from public offerings, net | $1.7M | $13.4M |
| Proceeds from private placement, net | $1.3M | $0 |
| Proceeds from equity line of credit, net | $5.9M | $0 |
| Repayment of insurance premium financing liability | -$96.6K | $0 |
| Proceeds from exercise of stock options | $0 | $19.1K |
| Net cash provided by financing activities | $8.9M | $13.3M |
| Net change in cash and cash equivalents | -$2.5M | $2.8M |
| Financed insurance premium exchanged for prepaid insurance | $295.6K | $0 |
| Purchases of fixed assets in accounts payable | $0 | $46.0K |
Former names
- Azitra IncMar 20, 2017 to Jan 4, 20242
Recent filings
- Oct 1, 20268-K
- Sep 28, 2026424B5
- Sep 28, 20268-K
- Sep 8, 20268-K
- Aug 21, 20268-K
- Aug 14, 2026SCHEDULE 13G
- Aug 14, 2026SCHEDULE 13G
- Aug 12, 202610-Q
- Aug 12, 20268-K
- Jul 15, 20268-K
- Jun 25, 2026SCHEDULE 13G
- Jun 24, 2026SCHEDULE 13D
- Jun 22, 2026SCHEDULE 13G
- Jun 18, 20264
- Jun 17, 20268-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAzitra, Inc. filings on SEC EDGAR
- 2SEC EDGARAzitra, Inc. filings on SEC EDGAR
- 3SEC EDGARAzitra, Inc. 10-K for fiscal 2025
- 4SEC EDGARAzitra, Inc. 10-K for fiscal 2022
- 5SEC EDGARAzitra, Inc. 10-K for fiscal 2023
- 6SEC EDGARAzitra, Inc. 10-Q for fiscal 2026
- 7SEC EDGARAzitra, Inc. 10-Q for fiscal 2026